Suppr超能文献

相似文献

1
Heart disease: Death-defying plaque cells.
Nature. 2016 Aug 4;536(7614):32-3. doi: 10.1038/nature18916. Epub 2016 Jul 20.
2
Morphologic features of culprit lesions in sudden coronary death with family history of premature coronary artery disease.
Forensic Sci Int. 2016 Sep;266:412-415. doi: 10.1016/j.forsciint.2016.06.033. Epub 2016 Jul 1.
3
Pathomorphological and CT-angiographical characteristics of coronary atherosclerotic plaques in cases of sudden cardiac death.
Int J Legal Med. 2015 Sep;129(5):1067-77. doi: 10.1007/s00414-015-1191-5. Epub 2015 Apr 24.
5
Sudden cardiac death from the perspective of coronary artery disease.
Mayo Clin Proc. 2014 Dec;89(12):1685-98. doi: 10.1016/j.mayocp.2014.08.022. Epub 2014 Oct 31.
6
Sudden coronary death caused by pathologic intimal thickening without atheromatous plaque formation.
Cardiovasc Pathol. 2011 Jan-Feb;20(1):51-7. doi: 10.1016/j.carpath.2009.08.004. Epub 2009 Nov 12.
7
[Sudden cardiac death related to coronary artery disease. Is the risk different for women?].
Presse Med. 2016 Oct;45(10):839-844. doi: 10.1016/j.lpm.2016.07.002. Epub 2016 Aug 17.
8
Macrolides use and the risk of sudden cardiac death.
Expert Rev Anti Infect Ther. 2016 Jun;14(6):535-7. doi: 10.1080/14787210.2016.1179580. Epub 2016 May 3.
10
[Clinical value of DC and DRs in warning sudden cardiac death of patients with coronary artery disease].
Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2017 Mar 8;33(3):244-247. doi: 10.12047/j.cjap.5509.2017.060.

引用本文的文献

1
Myeloid Cell Diversity and Impact of Metabolic Cues during Atherosclerosis.
Immunometabolism. 2020 Oct;2(4):immunometab20200028. doi: 10.20900/immunometab20200028.
3
Macrophage Inflammation, Erythrophagocytosis, and Accelerated Atherosclerosis in Jak2 Mice.
Circ Res. 2018 Nov 9;123(11):e35-e47. doi: 10.1161/CIRCRESAHA.118.313283.
4
Blending Electronics with the Human Body: A Pathway toward a Cybernetic Future.
Adv Sci (Weinh). 2018 Aug 1;5(10):1700931. doi: 10.1002/advs.201700931. eCollection 2018 Oct.
6
CAMKIIγ suppresses an efferocytosis pathway in macrophages and promotes atherosclerotic plaque necrosis.
J Clin Invest. 2017 Nov 1;127(11):4075-4089. doi: 10.1172/JCI94735. Epub 2017 Oct 3.
7
Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms.
FASEB J. 2017 Apr;31(4):1273-1288. doi: 10.1096/fj.201601222R. Epub 2017 Jan 13.
8
Macrophage Apoptosis and Efferocytosis in the Pathogenesis of Atherosclerosis.
Circ J. 2016 Oct 25;80(11):2259-2268. doi: 10.1253/circj.CJ-16-0924. Epub 2016 Oct 8.

本文引用的文献

1
CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis.
Nature. 2016 Aug 4;536(7614):86-90. doi: 10.1038/nature18935. Epub 2016 Jul 20.
2
Pre-Clinical Development of a Humanized Anti-CD47 Antibody with Anti-Cancer Therapeutic Potential.
PLoS One. 2015 Sep 21;10(9):e0137345. doi: 10.1371/journal.pone.0137345. eCollection 2015.
3
Phagocytosis of apoptotic cells in homeostasis.
Nat Immunol. 2015 Sep;16(9):907-17. doi: 10.1038/ni.3253.
5
Pro-resolving lipid mediators are leads for resolution physiology.
Nature. 2014 Jun 5;510(7503):92-101. doi: 10.1038/nature13479.
6
Phagocytosis of Staphylococcus aureus by human neutrophils prevents macrophage efferocytosis and induces programmed necrosis.
J Immunol. 2014 May 15;192(10):4709-17. doi: 10.4049/jimmunol.1302692. Epub 2014 Apr 11.
7
Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis.
J Clin Invest. 2014 Mar;124(3):1083-97. doi: 10.1172/JCI70391. Epub 2014 Feb 17.
8
A role of RIP3-mediated macrophage necrosis in atherosclerosis development.
Cell Rep. 2013 Jan 31;3(1):200-10. doi: 10.1016/j.celrep.2012.12.012. Epub 2013 Jan 17.
9
Anti-inflammatory therapy in chronic disease: challenges and opportunities.
Science. 2013 Jan 11;339(6116):166-72. doi: 10.1126/science.1230720.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验